Registration

ACG ADVOCACY for BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.

Firm
Client
Income
—
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Cost Sharing (Preserving Access to Medicines). Healthcare Exchanges. Average Sales Price. Reimbursements. CHIP. Rebates for Dual Eligibles and Low-Income Subsidy Populations in Medicare Part D. Importation. Non-Interference. 21st Century Cures.

LobbyistCovered position, as disclosed
STUART CHAPMAN New Chief of Staff, Representative Carolyn McCarthy; Chief of Staff, Representative Zack Space; Press Secretary, Senator Jay Rockefeller; Press Secretary, Representative Barbara Lee
SHERYL COHEN New —
CHRIS ISRAEL New —
STEPHEN PINKOS New —

Health Issues HCR

Cost Sharing (Preserving Access to Medicines). Healthcare Exchanges. Average Sales Price. Reimbursements. CHIP. Rebates for Dual Eligibles and Low-Income Subsidy Populations in Medicare Part D. Importation. Non-Interference. 21st Century Cures.

LobbyistCovered position, as disclosed
STUART CHAPMAN New Chief of Staff, Representative Carolyn McCarthy; Chief of Staff, Representative Zack Space; Press Secretary, Senator Jay Rockefeller; Press Secretary, Representative Barbara Lee
SHERYL COHEN New —
CHRIS ISRAEL New —
STEPHEN PINKOS New —

Foreign entities

Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.

EntityCountryPrincipal place of businessOwnershipContribution declared
BOEHRINGER INGELHEIM GMBH Germany Germany 100.0% —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.